Taicang Day celebrates deepening China-Germany cooperation
Hamburg, Germany - The Taicang Day event was held Thursday in the northern German city of Hamburg, with participants highlighting the broad prospects for continued win-win cooperation between China and Germany.

Neighboring Shanghai, the city of Taicang, spanning approximately 800 square kilometers, is known as the "hometown of German enterprises" in China, with over 530 German enterprises flocking here.
Nearly 200 representatives attended the Taicang Day event, including those from Chinese and German business sectors, leaders of German companies and project stakeholders.
Zhai Qian, minister of economic and commercial affairs at the Chinese Embassy in Germany, noted that the Taicang story perfectly exemplifies the win-win nature of China-Germany economic and trade cooperation.
"As China accelerates the development of new quality productive forces, there is significant potential for expanding China-Germany cooperation in emerging fields such as scientific and technological innovation, green and low-carbon development, clean energy, the circular economy, and the digital economy," he said.
"German companies have found strong partners in Taicang, partners who bring both expertise and openness to new ideas," said Michael Schumann, chairman of the Board of the German Federal Association for Economic Development and Foreign Trade.
"Whether in industrial manufacturing, the automotive sector, environmental technology, or renewable energy, the potential for mutual benefit is immense. This cooperation not only fosters job creation and economic growth in both countries but also drives technological advancements and innovations that are crucial in addressing the global challenges of our time," he said.
Kersten Janik, president of VAST LLC, told Xinhua, "We are in Taicang because we believe it offers the best opportunities for us to tap into the Chinese auto market."
"I first worked in China in 1990, and since then, I've witnessed the tremendous development in the country's industry and society. I deeply appreciate this progress, and I believe China is a perfect partner for Germany," he said.
Contact:
Pingping Feng
+86 2583109665
Images

Subscribe to releases from news aktuell GmbH
Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from news aktuell GmbH
INTERSPORT Austria acquires INTERSPORT Slovenia Group15.1.2026 15:16:10 CET | Press release
Strategic move strengthens market position in Central Europe, with over 500 locations in 12 countries and more than € 1 billion in sales
VORN Bioenergy announces appointments to leadership team15.1.2026 11:14:45 CET | Press release
Regensburg. VORN Bioenergy today announces the appointment of Jörg Lennertz as Chief Executive Officer and Manuel Fernández Durán as Chief Financial Officer. Jörg and Manuel together with Michael Wallis Olausson form the new management team.
Vyoma’s first Space Domain Awareness satellite has reached orbit13.1.2026 13:42:00 CET | Press release
Munich, 13. January 2026 - Vyoma, a Germany-based company providing Space Domain Awareness (SDA) capabilities, has launched its pioneering surveillance satellite, Flamingo-1, on Sunday, January 11th, 2026 from Vandenberg Space Force Base, California, USA. It was launched aboard the Twilight rideshare mission with SpaceX via Germany-based launch integrator Exolaunch. The satellite was deployed to its operational Sun-synchronous orbit of approximately 500-km in altitude. This marks a significant achievement for the company, which patented the operational concept of an optimized SDA mission. Flamingo-1, equipped with an optical sensor for space-based space surveillance, is a gamechanger for Europe, strengthening SDA efforts directly from orbit. The advanced optical instrument will detect, track and characterize space objects, such as debris and other satellites. Crucially, it will allow Vyoma and its customers to follow up on manoeuvring objects and derive insights into adversary actions
ORTEC expands German healthcare footprint with strategic acquisition of Klages & Partner13.1.2026 09:00:00 CET | Press release
Acquisition adds over 200 healthcare customers and sector-specific workforce management expertise to ORTEC’s portfolio
Acousia Announces Completion of Patient Enrollment in Phase 2 PROHEAR Study Evaluating ACOU085 (INN: Bimokalner) for the Prevention of Cisplatin-Induced Ototoxicity8.1.2026 09:00:00 CET | Press release
Tübingen, Germany, January 8, 2026 Acousia Therapeutics GmbH, a clinical-stage biotechnology company developing treatments for acute and chronic inner ear hearing loss, announced the completion of patient enrollment in its Phase 2 PROHEAR clinical study. ACOU085 (INN: Bimokalner) is a proprietary, first-in-class small molecule that has demonstrated robust and reproducible efficacy across multiple preclinical hearing loss models, including drug-induced ototoxicity. The PROHEAR Study is a double-blind, randomized, placebo-controlled, split-body, multicenter Phase 2 trial. It enrolled young male patients with metastatic testicular cancer who are scheduled to receive cisplatin-based chemotherapy. While cisplatin is a highly effective chemotherapeutic agent, cumulative doses of ≥300 mg/m² lead to clinically meaningful, permanent hearing loss in the majority of patients. Fifteen leading university hospitals in Germany are participating in this interdisciplinary study. Patients are randomized
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom